[Experiences with Lysodren treatment of Cushing's syndrome in dogs].
D000309:Adrenal Insufficiency / Q000139:chemically induced / Q000662:veterinary; D000818:Animals; D002493:Central Nervous System Diseases / Q000139:chemically induced / Q000662:veterinary; D003480:Cushing Syndrome / Q000188:drug therapy / Q000662:veterinary*; D004283:Dog Diseases / Q000139:chemically induced / Q000188:drug therapy*; D004285:Dogs; D004334:Drug Administration Schedule / Q000662:veterinary; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000662:veterinary; D008297:Male; D008939:Mitotane / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012871:Skin Diseases / Q000139:chemically induced / Q000662:veterinary
D008939:Mitotane
Erfahrungen mit der Lysodren-Behandlung des Cushing-Syndroms beim Hund (2).